New Nanoparticle Treatment Targets Lung Tumors and Muscle Loss Simultaneously
What Happened
Researchers at Oregon State University developed an experimental nanoparticle-based therapy that reduced lung tumors in mice while also countering cachexia, a severe muscle-wasting condition often seen in cancer patients. The treatment uses lipid nanoparticles to deliver follistatin mRNA directly to lung tumors, prompting cells to produce a protein that both suppresses tumor growth and supports muscle tissue.
Key Takeaways
The approach could potentially address two major challenges faced by lung cancer patients at once: cancer progression and debilitating muscle loss. In animal studies, the therapy reduced tumor burden more effectively than conventional approaches while preserving body weight, muscle mass and fat tissue without significant adverse effects.